InsiderTrades

Form 4 for BDSX BIODESIX INC

Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0000905148-25-002981 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-14 2025-08-13 BDSX Pestano Gary Anthony Chief Development Off S - Sale+OE $0.42 -442 157.9K -0.3% -$185.64
D 2025-08-14 2025-08-12 BDSX Pestano Gary Anthony Chief Development Off M - OptEx — +1,379 158.3K +0.9% —
D 2025-08-14 2025-08-12 BDSX Pestano Gary Anthony Chief Development Off M - OptEx $0.00 -1,379 2,756 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-13 S D 442 $0.42 157,878 D — — (F3) The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2 Common Common Stock 2025-08-12 M A 1,379 — 158,320 D — — (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
3 Derivative Restricted Stock Units 2025-08-12 M D 1,379 $0.00 2,756 D — · — to — 1,379 Common Stock (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.